C07D 295/116
With the doubly bound oxygen or sulfur atoms directly attached to a
Official title: with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring
C07D295/116 (With the doubly bound oxygen or sulfur atoms directly attached to a) appears on 125 US grants and 75 published applications in this corpus.
Search patents in C07D- Granted patents
- 125
- Published applications
- 75
- Assignees
- 91
- Inventors
- 395
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 5 | 0 |
| 1978 | 3 | 0 |
| 1979 | 5 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 4 | 0 |
| 1984 | 8 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 0 |
| 2002 | 2 | 5 |
| 2003 | 2 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 1 | 4 |
| 2007 | 0 | 2 |
| 2008 | 1 | 3 |
| 2009 | 1 | 3 |
| 2010 | 1 | 3 |
| 2011 | 2 | 2 |
| 2012 | 1 | 3 |
| 2013 | 3 | 3 |
| 2014 | 1 | 4 |
| 2015 | 4 | 6 |
| 2016 | 7 | 7 |
| 2017 | 2 | 3 |
| 2018 | 4 | 3 |
| 2019 | 5 | 5 |
| 2020 | 2 | 1 |
| 2021 | 2 | 2 |
| 2022 | 2 | 4 |
| 2023 | 1 | 1 |
| 2024 | 2 | 3 |
| 2025 | 1 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- N,N diethyl-N'phenylpiperazine alpha 7 and alpha 9 nicotinic acetylcholine receptor agonists and antagonists6 May 2025US 12,291,501 B2University of Florida Research Foundation, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives30 Jul 2024US 12,049,439 B2OrsoBio, Inc.
- N,N diethyl-N'phenylpiperazine alpha 7 and alpha 9 nicotinic acetylcholine receptor agonists and antagonists30 Jan 2024US 11,884,629 B2University of Florida Research Foundation, Inc.
- 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases12 Dec 2023US 11,840,497 B2PTC Therapeutics, Inc.
- Novel compounds with mtorc2-inhibitory activity and uses thereof10 Sep 2026US 2026/0265267 A1Aliad Biopharma
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Compositions, methods, and development of arid4b inhibitors27 Mar 2025US 2025/0099405 A1The George Washington University
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives12 Dec 2024US 2024/0409508 A1OrsoBio, Inc.
- N,N diethyl-N'phenylpiperazine alpha 7 and alpha 9 nicotinic acetylcholine receptor agonists and antagonists21 Mar 2024US 2024/0092738 A1University of Florida Research Foundation, Inc.
Most cited
By later US patents
- Muscarinic antagonists74US 5,883,096 ASchering Corporation · 1999
- Muscarinic antagonists58US 5,889,006 ASchering Corporation · 1999
- Method of using alpha-keto enamine derivatives as ingredients and products incorporating same56US 6,592,884 B2Nestec S. A. · 2003
- 4-Amino-4-phenylcyclohexanone ketal compositions and process of use51US 4,065,573 AThe Upjohn Company · 1977
- Muscarinic antagonists44US 6,037,352 ASchering Corporation · 2000